Authors	Title	Reference
Stone NN, Stock RG	Practical considerations in permanent brachytherapy for localized adenocarcinoma of the prostate	Urol Clin N Am 30 (2003) 351-362
Stock RG, Stone NN, Dahlal M, Lo YC	What is the optimal dose for 125I prostate implants? A dose-response analysis of biochemical control, posttreatment prostate biopsies, and long-term urinary symptoms	Brachytherapy 1 (2002) 83-89
Stock RG, Stone NN	Importance of Post-Implant Dosimetry in Permanent Prostate Brachytherapy	European Urology 41 (2002) 434-439
Stock RG, Hong S, Lo YC, Howard V, Stone NN	Comparison of intraoperative dosimetric implant representation with postimplant dosimetry in patients receiving prostate brachytherapy	Brachytherapy 2 (2003) 17-25
Stone NN, Stock RG	Reduction of pulmonary migration of permanent interstitial sources in patients undergoing prostate brachytherapy	J. Urology 66 (1), 2005, 119-123
Stock RG, Stone NN et al.	Combined modality treatment in the management of high-risk prostate cancer	Int. J. Radiation Oncology Biol. Phys, Vol. 59, No. 5, (2004) 1352-1359
Cesaretti JA, Stone NN, Stock RG	Does prior transurethral resection of prostate compromise brachytherapy quality: A dosimetric analysis	Int. J. Radiation Oncology Biol. Phys, Vol. 60, No. 2, (2004) 648-653
Ash D et al.	ESTRO/EAU/EORTC recommendations on permanent seed implantation for localized prostate cancer	Radiotherapy and Oncology 57 (2000) 315-321
Nag S, Grimm P et al.	American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer	Int. J. Radiation Oncology Biol. Phys, Vol. 44, No. 4, (1999) 789-799
Stone NN, Stock RG, Unger P	Intermediate term biochemical-free progression and local control following 125Iodine brachytherapy for prostate cancer	J. Urology, 173 (2005) 803-807
Stone NN, Stock RG	Prospective assessment of patient-reported long-term urinary morbidity and associated quality of life changes after 125I prostate brachytherapy	Brachytherapy 2 (2003) 32-39
Tward JD, Lee CM	Survival of men with clinically localized prostate cancer treated with prostatectomy, brachytherapy, or no definitive treatment	Cancer Vol. 107, No. 10, (2006) 2392-2400
Reed D, Wallner K	Clinical correlates to PSA spikes and positive repeat biopsies after prostate brachytherapy	Urology 62 (4), (2003) 683-688
Zelefsky MJ	PSA bounce versus biochemical failure following prostate brachytherapy (commentary)	Nature Clinical Practice Urology Vol. 3, No. 11 (2006) 578-579
Grocela J, Mauceri T	New life after prostate brachytherapy? Considering the fertile female partner of the brachytherapy patient	BJU International 96, (2005) 781-782

 

Die oben angegebenen Links verweisen auf die Seiten von www.pubmed.gov.

Mit Anklicken der angebotenen Links verlassen Sie die Webseite der C. R. Bard GmbH. Alle Links oder Verweise auf andere Internetseiten (Hyperlinks) werden den Nutzern dieser Internetseite von Bard lediglich als Gefälligkeit zur Verfügung gestellt. Kein Hyperlink auf eine andere Internetseite stellt eine Billigung oder Empfehlung durch Bard oder eine der Tochtergesellschaften dar. Bitte beachten Sie dazu auch die zusätzlichen Informationen in unseren Nutzungsbedingungen ("Terms of Use").